FTRE Fortrea Corp Earnings per share for the last twelve months

Corporate company logo of fortrea.com (FTRE)

The EPS TTM history on GURU.Markets is available for analysis, with the latest value recorded as -0.73. Fortrea Holdings Inc. (FTRE) relies on multi-year drug development contracts that create a resilient order book. Strict procedural inertia when switching laboratories ensures a steady stream of service revenue. However, operational complexities following the business spin-off and reductions in biotech budgets are weighing on margins.

Fortrea Holdings Inc. (FTRE) - Earnings per share for the last four quarters from 02/21/2024 to 11/18/2026

Comprehensive metric breakdowns and analytics for Fortrea Clinical (FTRE)

- stock price and consensus target price:
Basic company analysis:FTRE - Fortrea
Manufactured products of Fortrea Corp

Net income per share over 12 months measures the actual return on each unit of capital, neutralizing the impact of total issuance volume to assess business scaling efficiency. Analyzing the trailing 12-month net income per share allows for the identification of Fortrea Holdings Inc. (FTRE) resilience against biotech client budget cuts and clinical trial cancellation risks, determining the real value of the company's assets.